AI Article Synopsis
Article Abstract
Objective: The objective of this study was to investigate the non-Gaussian water diffusion properties in bladder cancer and assess the efficacy of diffusion kurtosis imaging for estimating the histological grade of bladder cancer.
Methods: Twenty-one patients with bladder cancer (high-grade, 12; low-grade, 9) and 17 negative controls who underwent preoperative 3.0-T magnetic resonance imaging including multi-b value diffusion-weighted imaging (b values, 0, 500, 800, 1200, 1500, and 2000 s/mm) were included. Besides apparent diffusion coefficient (ADC) maps, diffusion kurtosis imaging maps for diffusion coefficient (Dapp) and kurtosis (Kapp) were also obtained. Data were analyzed using the Mann-Whitney U test, Spearman correlation test, and receiver operating characteristic curves.
Results: Bladder cancer showed significantly lower ADC values, lower Dapp values, and higher Kapp values compared with normal bladder wall (all P < 0.001). The Kapp values were significantly higher in high-grade than in low-grade tumors (P = 0.007). Significant correlations were found between Dapp and ADC (r = 0.901, P < 0001) as well as between Kapp and ADC (r = -0.910, P <0.001). The areas under the receiver operating characteristic curve were 0.843 and 0.796 for estimation of high-grade bladder cancer by using the Kapp values and ADC values, respectively.
Conclusions: Diffusion in bladder cancer follows a non-Gaussian behavior. The new metric Kapp may potentially serve as a biomarker of grade of bladder cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RCT.0000000000000197 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells.
Biomater Sci
January 2025
Department of Urology, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, 410013, Hunan, China.
Gemcitabine (GEM) is a first line chemotherapy drug for bladder cancer (BCa). GEM's lack of specificity has led to disadvantages, resulting in low efficiency, especially when combined with the targeted treatment of BCa stem cells (CSCs), which is considered the cause of BCa recurrence and progression. To enhance the anti-cancer effect and reduce the side effects of GEM targeting of BCa cells/CSCs, an aptamer drug conjugate (ApDC) targeted delivery system was used to improve the efficiency of GEM in BCa therapy using EpCAM aptamer-GEM conjugates based on the epithelial cell adhesion molecule (EpCAM), which is highly expressed on the cell membrane of BCa cells/CSCs.
View Article and Find Full Text PDFThe effect of neoadjuvant chemotherapy on survival outcomes in patients with variant histologies who underwent radical cystectomy with precystectomy diagnostic accuracy: A multicenter study of the Turkish Urooncology Association.
Int J Urol
January 2025
Department of Urology, School of Medicine, Ankara University, Ankara, Turkey.
Objectives: To evaluate the role of neoadjuvant chemotherapy in the final treatment plan and its impact on survival in bladder cancer patients who were diagnosed with variant histology in the radical cystectomy specimen and whose diagnostic accuracy was achieved with the previous transurethral resection of the bladder specimen.
Methods: In this retrospective multicenter study, data from 221 patients across 9 centers were analyzed between January 2012 and January 2022. The primary endpoint was overall, cancer-specific, recurrence-free, and metastasis-free survival rates among patients with and without neoadjuvant chemotherapy, and the secondary endpoint was to identify independent predictors of survival.
En bloc resection of large bladder tumor: is it feasible and reasonable?
Curr Opin Urol
January 2025
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Purpose Of Review: Transurethral resection of bladder tumor (TURBT) remains the basis of bladder tumor diagnosis and an effective means of treating nonmuscle invasive bladder cancer (NMIBC). There are several limitations to this procedure: TURBT may cause free floating of malignant cells in the bladder and as a result re-implantation and early recurrence. Also, it does not allow the pathologist to define the correct spatial orientation of the specimen.
View Article and Find Full Text PDFMethyltransferase-like 7B participates in bladder cancer via ACSL3 mA modification in a ferroptosis manner.
Biol Direct
January 2025
Department of Urology, The First Hospital of China Medical University, 155 North Nanjing Street, Heping District, Shenyang, Liaoning, China.
Background: Bladder cancer (BC) is a malignant tumor. Methyltransferase-like 7B (MEETL7B) is a methyltransferase and its role in BC has not yet been revealed.
Method: Stable METTL7B knockdown or overexpression were achieved by lentiviral transduction in SW780 and TCCSUP cell lines.
"Δ" Delta neobladder: a novel stentless simplified totally intracorporeal robotic technique.
Minerva Urol Nephrol
December 2024
Department of Urology, Campus Bio-Medico University Polyclinic Foundation, Rome, Italy.
Background: To report the first case series of RARC using a simplified technique for intracorporeal stentless neobladder formation.
Methods: From October 2022 to February 2023, 10 patients with high-risk bladder cancer underwent RARC at our Institution. RARC with extended pelvic lymph node dissection and totally intracorporeal neobladder using Hugo RAS system.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!